You must log in to view this page.

Cullinan Therapeutics Inc. – Ownership Summary

NASDAQ: CGEM
Share price (6/3/26): $15.21
Market cap (6/3/26): $935 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Google Finance
SEC EDGAR

Insider Ownership

Michaelson Jennifer »

12/34/56

144

12/34/56

144

12/34/56

Ahmed Nadim »

12/34/56

≥5% Ownership

Biotechnology Value Fund L P »

SCHEDULE 13G/A

SCHEDULE 13G/A

SC 13G/A

SC 13G/A

SC 13G/A

Vanguard Group Inc »

SCHEDULE 13G/A

SCHEDULE 13G

SCHEDULE 13G/A

SC 13G/A

SC 13G/A

Cullinan Therapeutics Inc. – Ownership Summary Watch

Search in Documents

Key Exhibits

External Links

Insider Ownership

Michaelson Jennifer »

Ahmed Nadim »

≥5% Ownership

Biotechnology Value Fund L P »

Vanguard Group Inc »

Cullinan Therapeutics Inc. – Ownership Summary